Maxime Fontanilles

9PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyGenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 30, 2025
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Dinu Stefan, Paul Lesueur, Justine Lequesne

|Oct 11, 2024
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.

Maxime Fontanilles, Jean-David Heisbourg, Arthur Daban

|Oct 23, 2021
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma.

Vianney Gilard, Justine Ferey, Florent Marguet

|Apr 30, 2021
Diagnosis and Management of Glioblastoma: A Comprehensive Perspective.

Vianney Gilard, Abdellah Tebani, Ivana Dabaj

|Apr 03, 2021
TERT Promoter Alterations in Glioblastoma: A Systematic Review.

Nathalie Olympios, Vianney Gilard, Florent Marguet

Pageof 2